Electra Therapeutics, Inc.ETRA

NasdaqHealthcareBiological Products, (No Diagnostic Substances)
Price (close)
$11.82
Market cap
—
P/E
—
Revenue (FY)
—
Net income
—
Dividend yield
—
1-year total return
—
Net margin
—
Revenue growth
—
Debt / equity
—

What Electra Therapeutics, Inc. does.

No business description on file yet.

More on ETRA.

Figures from Electra Therapeutics, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.